Insights about U.S. Stocks from mix sectors that landed in the Green-Zone in the course of Tuesday’s trade, are depicted underneath:

OncoGenex Pharmaceuticals Inc (NASDAQ:OGXI)’s shares picked up 7.88%, and closed at $ 2.60, during the last trading session.

OncoGenex Pharmaceuticals, Inc. and Sarah Cannon formerly on February 24, declared that patient enrollment has been accomplished in the Spruce™ clinical trial, an investigator-sponsored, randomized, placebo-controlled Phase 2 trial evaluating apatorsen in combination with carboplatin and pemetrexed in patients with formerly untreated, advanced, non-squamous, non-small cell lung cancer (NSCLC). Spruce is sponsored and led by Sarah Cannon Research Institute (SCRI), the research arm of Sarah Cannon , Hospital Corporation of America’s (HCA) global cancer enterprise, and is being conducted at 16 sites across the United States .

In the Spruce trial, about 155 patients were randomized to receive either apatorsen or placebo in combination with carboplatin and pemetrexed therapy. The primary objective of the trial is progression-free survival (PFS), with additional analyses to evaluate overall survival, tumor response rates, safety, tolerability and the effect of therapy on heat shock protein 27 (Hsp27) levels.

“Despite advances in targeted therapies to treat lung cancer, the majority of patients lack specific biomarkers and chemotherapy remains a mainstay of treatment for these patients,” stated David Spigel MD, Director of the Lung Cancer Research Program at Sarah Cannon Research Institute and trial study chair. “The Spruce trial will enable us to better understand the role of apatorsen in treating NSCLC and its potential to delay or prevent treatment resistance and improve survival outcomes for these patients who urgently need more effective treatment options.”

OncoGenex Pharmaceuticals, Inc., a biopharmaceutical corporation, develops and commercializes therapies that address treatment resistance in cancer patients. Its lead drug candidate, Custirsen is in Phase III clinical development for the treatment in men with metastatic castrate-resistant prostate cancer, and in patients with advanced, unresectable non-small cell lung cancer.

BreitBurn Energy Partners L.P (NASDAQ:BBEP), raised 7.80%, and closed at $ 7.88, hitting new 52-week high of $14.37.

Breitburn Energy Partners L.P. declared financial and operating results for the fourth quarter and full year 2014.

Key Highlights:

• Closed on the attainments of QR Energy and planned bolt-on acreage in the Permian Basin for about $2.7 billion, counting debt assumed.
• Raised fourth quarter 2014 production to 4.2 million Boe, a 35% raise from fourth quarter 2013, and raised full year production to 14.1 million Boe, a 29% raise from 2013. Not including production from QR Energy assets, Breitburn’s production raised 6% in the fourth quarter 2014 contrast to fourth quarter 2013 and 20% for 2014 contrast to 2013. Annual production was in line with the forecast in Breitburn’s third quarter Form 10Q.
• Raised Adjusted EBITDA, a non-GAAP financial measure, to $127.4 million (counting attainment and integration costs of $11.7 million), a 7% raise from third quarter 2014. Raised full year Adjusted EBITDA to $473.8 million (counting attainment and integration costs of $14.5 million), a 28% raise from 2013.
• Total estimated proved reserves as of December 31, 2014, were 315.3 million Boe contrast to 214.3 million Boe as of December 31, 2013, a 47% raise.
• Total oil and gas capital expenditures for 2014 were $389 million, a 32% raise from 2013. Not including capital spending of $25 million attributable to QR Energy assets, 2014 capital spending was within the range that was forecast in Breitburn’s third quarter Form 10Q.

BreitBurn Energy Partners L.P., an independent oil and gas corporation, attains, explores, and develops oil, natural gas liquids (NGLs), and gas properties in the United States. The corporation’s oil, NGL, and natural gas properties are primarily located in the Antrim Shale and other non-Antrim formations in Michigan; the Oklahoma Panhandle, the Permian Basin in Texas; the Evanston, Green River, Wind River, Big Horn, and Powder River Basins in Wyoming; the Los Angeles and San Joaquin Basins in California; the Sunniland Trend in Florida; and the New Albany Shale in Indiana and Kentucky.

Merge Healthcare Inc (NASDAQ:MRGE), enhanced 7.67%, and closed at $4.49.

Merge Healthcare Incorporated, a leading provider of health information systems for medical imaging, interoperability, and communication, declared its financial and business results for the fourth quarter of 2014.

Merge Healthcare also recently attained DR Systems, a privately held San Diego-based corporation with a strong reputation for customer satisfaction in medical imaging information systems. The combined entities provide an unprecedented array of highly rated healthcare information technology products. According to the KLAS Research ratings released on January 29, 2015, the go forward business will rank #1 in cardiovascular information systems, #1 in hemodynamics monitoring and #1 in radiology information systems. “I’m thrilled to add the talents, technologies, and intellectual property that have made the DR Systems brand synonymous with customer satisfaction. Merge and DR Systems share a ordinary heritage of creating and maintaining long-term partnerships with our healthcare customers. This attainment reflects Merge’s commitment to delivering solutions that enable our healthcare partners to elevate their clinical success, financial results, and the health of their communities. This attainment also greatly expands our market share, which we believe is extremely important given the provider consolidation that is underway. Further, the attainment will allow us to deploy our iConnect Network services, counting pre-authorization services, to a broader client footprint right away,” stated Mr. Dearborn.

Murray Reicher, M.D., F.A.C.R., founder, chairman, and chief executive officer of DR Systems, will assume the role of chief medical officer of Merge Healthcare. Dr. Reicher is a board-certified diagnostic radiologist and Fellow of the American College of Radiology, and is recognized for his numerous scientific publications, inventions, and presentations in the fields of neuroradiology, musculoskeletal MRI, and health information technologies.

Merge Healthcare Incorporated develops software solutions that facilitate the sharing of images to create an electronic healthcare experience for patients and physicians worldwide. It operates in two segments, Merge Healthcare and Merge DNA. The corporation provides iConnect Enterprise Archive and iConnect Access Enterprise Viewer, an interoperability and connectivity platform for imaging and diagnostic data access; iConnect Network to electronically manage in-bound medical imaging referrals and distribution of results to referring physicians; iConnect Cloud Archive, a cloud-based and multi-tenant image archive that provides disaster recovery/business continuity services; and iConnect Retinal Screening, a software solution for the screening of chronic visual diseases.

Wayfair Inc (NYSE:W), enhanced 7.17%, and closed at $25.25.

Wayfair Inc. Birch Lane, a retailer of classic furnishings and timeless home décor, declared free shipping on all orders over $49. While shoppers have come to expect free shipping in categories such as books, clothing, footwear and electronics, shipping costs for furniture and home décor have remained high across most online and catalog retailers. In fact, the average shipping cost for a $1200 sofa from a national catalog retailer is about $230. Shoppers can now save hundreds of dollars on furniture orders by shopping Birch Lane’s selection of competitively priced traditional home furnishings and décor.

“Customers expect free shipping from the major ecommerce players yet most lifestyle retailers in the home furnishings sector continue to tack on substantial shipping charges per every order,” noted Meredith Mahoney, general manager of Birch Lane. “As a Wayfair brand, we have access to one of the most sophisticated shipping and logistics networks in retail which allows us to extend great savings to Birch Lane customers. We are offering customers great quality and value on timeless home furnishings without the exorbitant shipping costs. This comprises beds, sofas, armoires, bookcases and dressers – all items no matter how big or bulky. Smaller orders under $49 will continue to ship for the low price of $4.99.”

Birch Lane’s new shipping policy goes into effect recently.

Wayfair Inc. (NYSE:W) offers an extensive selection of home furnishings and décor across all styles and price points. In addition to Birch Lane, the Wayfair family of brands comprises:

• com, an online destination for all things home,
• Joss & Main, an online flash sales site offering inspiring home design daily,
• AllModern, a go-to online source for modern design,
• DwellStudio, a design house for fashion-forward modern furnishings.